Literature DB >> 17951046

Glycosylation engineering in yeast: the advent of fully humanized yeast.

Stephen R Hamilton1, Tillman U Gerngross.   

Abstract

Yeasts have been extensively used as model organisms to elucidate cellular processes and their mechanism in lower eukaryotes. Consequently, a large number of powerful genetic tools have been developed to engineer yeast and improve its utility. These tools and the development of efficient large-scale fermentation processes have made recombinant protein expression in yeast an attractive choice. However, for the production of glycoproteins for human use, native high-mannose yeast glycosylation is not suitable and therefore represents a major limitation for yeast based protein expression systems. Over the last two decades several groups have attempted to overcome this problem, yet with limited success. Recently however, major advances in the glycoengineering of the yeast Pichia pastoris, have culminated in the production of fully humanized sialylated glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951046     DOI: 10.1016/j.copbio.2007.09.001

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  77 in total

1.  Isotope labeling in insect cells.

Authors:  Krishna Saxena; Arpana Dutta; Judith Klein-Seetharaman; Harald Schwalbe
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

3.  New technologies for 21st century plant science.

Authors:  David W Ehrhardt; Wolf B Frommer
Journal:  Plant Cell       Date:  2012-02-24       Impact factor: 11.277

4.  EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity.

Authors:  Stéphane Olivier; Marine Jacoby; Cédric Brillon; Sylvana Bouletreau; Thomas Mollet; Olivier Nerriere; Audrey Angel; Sévérine Danet; Boussad Souttou; Fabienne Guehenneux; Laurent Gauthier; Mathilde Berthomé; Henri Vié; Nicola Beltraminelli; Majid Mehtali
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 5.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

Review 6.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

Review 7.  Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions.

Authors:  Lai-Xi Wang; Mohammed N Amin
Journal:  Chem Biol       Date:  2014-01-16

Review 8.  Emerging methods for the production of homogeneous human glycoproteins.

Authors:  Jamie R Rich; Stephen G Withers
Journal:  Nat Chem Biol       Date:  2009-04       Impact factor: 15.040

Review 9.  Chemoenzymatic Methods for the Synthesis of Glycoproteins.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Chem Rev       Date:  2018-08-24       Impact factor: 60.622

10.  Expression plasmids and production of EGFP in stably transfected Acanthamoeba.

Authors:  Erik Bateman
Journal:  Protein Expr Purif       Date:  2009-10-28       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.